Clinical Trial Update: Female Orgasmic Disorder (FOD) and Wellbutrin XL [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update indicating that Phase 2 and Phase 3 studies of Wellbutrin XL for female orgasmic disorder have been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Female Orgasmic Disorder

Drugs mentioned

• WELLBUTRIN XL (Bupropion hydrochloride)

Snippet

Sponsor: Segraves, R., T., M.D., Ph.D. | Conditions: Orgasmic Disorder | Phase 2, Phase 3 | Status: COMPLETED